SCHEMBL17528843

SCHEMBL17528843

Cc1ccc(-n2c3ccccc3c3cc4c(cc32)C(C)(C)c2cc3oc5ccccc5c3cc2-4)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.40
▸ MAOA P21397 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ KDM4E B2RXH2 5/20 0.36
▸ HTT P42858 1/20 0.36
▸ HPGD P15428 5/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ DUSP3 P51452 1/20 0.35
▸ PTPN5 P54829 1/20 0.35
▸ PTPN11 Q06124 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ NR2E3 Q9Y5X4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17528740 0.97 PGR (0.38) PGRMAOAALDH1A1KDM4EHTT
SCHEMBL18356909 0.92 ALDH1A1 (0.35) PGRMAOAALDH1A1KDM4EHTT
SCHEMBL18356471 0.92 KDM4E (0.43) PGRMAOAALDH1A1KDM4EHPGD
SCHEMBL18356967 0.90 KDM4E (0.39) PGRMAOAALDH1A1KDM4EHPGD
SCHEMBL18357123 0.90 PGR (0.37) PGRMAOAALDH1A1KDM4EHPGD
SCHEMBL18357122 0.89 PGR (0.36) PGRMAOAALDH1A1KDM4EHPGD
SCHEMBL17528715 0.89 PGR (0.37) PGRMAOAALDH1A1KDM4EHPGD
SCHEMBL15946324 0.89 MAPT (0.39) PGRMAOAALDH1A1KDM4EHPGD
SCHEMBL18357121 0.88 RAB9A (0.39) PGRMAOAALDH1A1KDM4EHTT
SCHEMBL17528977 0.87 PGR (0.35) PGRMAOAALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2017-01-05 — — US disclosed
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2017-01-05 — — US disclosed
WO-2016024637-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT 出光興産株式会社 2016-02-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170005274-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC EQUIPMENT LEF1, RPL6, OR10J3 PGR 2609/4885MAOA 1303/4885ALDH1A1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback